D-0171-2023 Class II Terminated
FDA drug recall D-0171-2023 was initiated by Ascend Laboratories, LLC on Jan 5, 2023 and is designated Class II. Reason for recall: Failed Dissolution Specification The recall status is terminated (terminated Aug 15, 2024). Affected quantity: 2628 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 1, 2023
- Initiation Date
- Jan 5, 2023
- Termination Date
- Aug 15, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2628 bottles
Product description
Metoprolol Succinate Extended-Release Tablets, USP 50 mg, Rx Only, 500 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany NJ 07054, NDC 67877-591-05.
Reason for recall
Failed Dissolution Specification
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot#: 21141321, 21141322, Exp 01/31/2023.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0171-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026